(1)
IMPROVING DIAGNOSTIC AND THERAPEUTIC APPROACHES TO ASSESS METABOLIC ACTIVITY OF THE GUT MICROBIOTA IN PATIENTS WITH ISCHEMIC HEART DISEASE. OJMNS 2026, 3 (2), 205-211.